| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0001795> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0007667> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0021368> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0022660> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0028296> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0028829> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0034242> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0034260> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0040225> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0085421> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0687133> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C0746624> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C1373187> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C1565662> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C1720825> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C1831808> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C1831809> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C2609414> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C2717795> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C2717796> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C2717797> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C2717798> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C3530466> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C3653500> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C3669283> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C5200801> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33908408_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/C0009817_MENTIONED_IN_33908408>
?:authorAffiliation	[\'Laboratoire de Pharmacologie-Toxicologie-Gaz du Sang, CHU de Saint-Etienne, Saint Etienne, France.\', \'Service de Médecine Intensive et Réanimation G, CHU de Saint-Etienne, Saint Etienne, France.\', \'INSERM U1059, Dysfonctions Vasculaires et de L\'Hémostase, Université de Lyon, Saint-Etienne, France.\', \'Service de Médecine Vasculaire et Thérapeutique, CHU de Saint-Etienne, Saint Etienne, France; and.\', \'Infectious Diseases Department, CHU de Saint-Etienne, Saint Etienne, France.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Botelho-Nevers_Elisabeth> <https://research.tib.eu/covid-19/entity/Delavenne_Xavier> <https://research.tib.eu/covid-19/entity/Demartin_Anne-Laure> <https://research.tib.eu/covid-19/entity/Launay_Manon> <https://research.tib.eu/covid-19/entity/Mismetti_Patrick> <https://research.tib.eu/covid-19/entity/Ragey_Sophie_Perinel>
?:doi	10.1097/FTD.0000000000000899
?:doi	<https://research.tib.eu/covid-19/entity/10.1097/FTD.0000000000000899>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Case_Reports> <https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Therapeutic drug monitoring
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33908408>
?:pmid	<https://research.tib.eu/covid-19/entity/33908408>
?:pmid	33908408
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.656
?:rankingScore_hIndex	84
?:title	Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Laboratoire de Pharmacologie-Toxicologie-Gaz du Sang, CHU de Saint-Etienne, Saint Etienne, France.\', \'Service de Médecine Intensive et Réanimation G, CHU de Saint-Etienne, Saint Etienne, France.\', \'INSERM U1059, Dysfonctions Vasculaires et de L\'Hémostase, Université de Lyon, Saint-Etienne, France.\', \'Service de Médecine Vasculaire et Thérapeutique, CHU de Saint-Etienne, Saint Etienne, France; and.\', \'Infectious Diseases Department, CHU de Saint-Etienne, Saint Etienne, France.\']

?:citedBy

-1

?:creator

?:doi

10.1097/FTD.0000000000000899

?:doi

<https://research.tib.eu/covid-19/entity/10.1097/FTD.0000000000000899>

?:hasPublicationType

?:journal

Therapeutic drug monitoring

is ?:pmid of

<https://research.tib.eu/covid-19/entity/33908408>

?:pmid

<https://research.tib.eu/covid-19/entity/33908408>

?:pmid

33908408

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

0.656

?:rankingScore_hIndex

?:title

Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round.

?:type

?:year

2021

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33908408>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33908408>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata